Current and emerging therapies for the treatment of pancreatic cancer

Por Moss, Rebecca A, Lee, Clifton
Publicado em 2010

Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management

Por Khan, Gazala, Moss, Rebecca A, Braiteh, Fadi, Saltzman, Marc
Publicado em 2014

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series

Por Hadzitheodorou, Christina, Moss, Rebecca A., Kennedy, Timothy J., Jabbour, Salma K.
Publicado no Case Rep Oncol (2017)

Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database

Por Yao, Kaelan J., Jabbour, Salma, Parekh, Niyati, Lin, Yong, Moss, Rebecca A.
Publicado no BMC Gastroenterol (2016)

A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer

Por Moss, Rebecca A., Moore, Dirk, Mulcahy, Mary F., Nahum, Kenneth, Saraiya, Biren, Eddy, Simantini, Kleber, Martin, Poplin, Elizabeth A.
Publicado em 2012

Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review

Por Newman, Neil B., Jabbour, Salma K., Hon, Jane Date C., Berman, Joseph J., Malik, Deen, Carpizo, Darren, Moss, Rebecca A.
Publicado no J Clin Exp Hepatol (2015)

A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors

Por Hecht, J Randolph, Raman, Steven, Sze, Daniel Y, Lockhart, A Craig, Moss, Rebecca A, Liu, Kate, Chou, Jeffrey, Reid, Tony
Publicado no J Immunother Cancer (2015)

Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer

Por Moss, Rebecca A., Moore, Dirk, Mulchahy, Mary F., Nahum, Kenneth, Li, Hui, Moore, Katen, Fischer, Jane, Konduri, Srivani, Durivage, Henry, Poplin, Elizabeth
Publicado em 2010

Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas

Por Newman, Neil B., Moss, Rebecca A., Maloney-Patel, Nell, Donohue, Kristen, Brown, Teresa V., Nissenblatt, Michael J., Lu, Shou-En, Jabbour, Salma K.
Publicado no J Gastrointest Oncol (2017)

Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors

Por Saraiya, Biren, Chugh, Rashmi, Karantza, Vassiliki, Mehnert, Janice, Moss, Rebecca A., Savkina, Nelli, Stein, Mark N., Baker, Laurence H., Chenevert, Thomas, Poplin, Elizabeth A.
Publicado no Invest New Drugs (2010)

A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)

Por Owonikoko, Taofeek K., Dahlberg, Suzanne E., Khan, Saad A., Gerber, David E., Dowell, Jonathan, Moss, Rebecca A., Belani, Chandra P., Hann, Christine L., Aggarwal, Charu, Ramalingam, Suresh S.
Publicado no Lung Cancer (2015)

Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer

Por Tunceroglu, Ahmet, Park, Joo Han, Balasubramanian, Sairam, Poppe, Matthew, Anker, Christopher J., Poplin, Elizabeth, Moss, Rebecca A., Yue, Ning J., Carpizo, Darren, Gannon, Christopher J., Haffty, Bruce G., Jabbour, Salma K.
Publicado em 2012

A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors

Por Leong, Stephen, Moss, Rebecca A., Bowles, Daniel W., Ware, Joseph A., Zhou, Jing, Spoerke, Jill M., Lackner, Mark R., Shankar, Geetha, Schutzman, Jennifer L., van der Noll, Ruud, Voest, Emile E., Schellens, Jan H.M.
Publicado no Oncologist (2017)

Intensity-Modulated Radiation Therapy for Rectal Carcinoma Can Reduce Treatment Breaks and Emergency Department Visits

Por Jabbour, Salma K., Patel, Shyamal, Herman, Joseph M., Wild, Aaron, Nagda, Suneel N., Altoos, Taghrid, Tunceroglu, Ahmet, Azad, Nilofer, Gearheart, Susan, Moss, Rebecca A., Poplin, Elizabeth, Levinson, Lydia L., Chandra, Ravi A., Moore, Dirk F., Chen, Chunxia, Haffty, Bruce G., Tuli, Richard
Publicado em 2012

Nivolumab in patients with metastatic DNA mismatch repair deficient/microsatellite instability–high colorectal cancer (CheckMate 142): results of an open-label, multicentre, phase...

Por Overman, Michael J., McDermott, Ray, Leach, Joseph L., Lonardi, Sara, Lenz, Heinz-Josef, Morse, Michael A., Desai, Jayesh, Hill, Andrew, Axelson, Michael, Moss, Rebecca A., Goldberg, Monica V., Cao, Z. Alexander, Ledeine, Jean-Marie, Maglinte, Gregory A., Kopetz, Scott, André, Thierry
Publicado no Lancet Oncol (2017)

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers

Por Hirshfield, Kim M., Tolkunov, Denis, Zhong, Hua, Ali, Siraj M., Stein, Mark N., Murphy, Susan, Vig, Hetal, Vazquez, Alexei, Glod, John, Moss, Rebecca A., Belyi, Vladimir, Chan, Chang S., Chen, Suzie, Goodell, Lauri, Foran, David, Yelensky, Roman, Palma, Norma A., Sun, James X., Miller, Vincent A., Stephens, Philip J., Ross, Jeffrey S., Kaufman, Howard, Poplin, Elizabeth, Mehnert, Janice, Tan, Antoinette R., Bertino, Joseph R., Aisner, Joseph, DiPaola, Robert S., Rodriguez-Rodriguez, Lorna, Ganesan, Shridar
Publicado no Oncologist (2016)